Answers are grounded in this paper and cite their sources.
Observational analysis explores the link between brain volume loss and clinical disability in primary progressive multiple sclerosis, questioning current trial endpoints.
The association of the investigated volumetric MRI measures and clinical disability outcomes was noticeably weak and inconsistent. Our findings question the suitability of brain volume loss and lesion burden accumulation as functionally relevant trial endpoints in PPMS and inform the design and interpretation of clinical trials in PPMS.
No takes yet. Share an insight, caveat, or question.
Koch et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: